Who
Brendan Delaney
Director
Company insider
Files Form 4 as: Director, BeyondSpring; Chief Operating Officer, Whitehawk Therapeutics; Chief Commercial Officer, Immunomedics.
In numbers
- Trades disclosed
- 15
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 1
- First trade
- 10 Nov 2017
- Last trade
- 1 Apr 2026
- Last filed
- 3 Apr 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Apr 2026filed 3 Apr 2026 | BYSI BeyondSpringoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,427 at $0.00 | filing |
| 1 Apr 2026filed 3 Apr 2026 | BYSI BeyondSpringoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,427 at $0.00 | filing |
| 21 Apr 2025filed 23 Apr 2025 | BYSI BeyondSpringoption or derivative · Biotechnology | SEC FORM 4 Code A | —21,822 at $0.00 | filing |
| 1 Mar 2023filed 2 Mar 2023 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —235,000 at $0.00 | filing |
| 3 Jan 2023filed 4 Jan 2023 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
| 26 Sep 2022filed 27 Sep 2022 | WHWK Whitehawk TherapeuticsBiotechnology | SEC FORM 4 Code A | $250K20,000 at $12.50 | filing |
| 1 Apr 2022filed 5 Apr 2022 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —61,000 at $0.00 | filing |
| 20 Sep 2021filed 22 Sep 2021 | WHWK Whitehawk Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —260,000 at $0.00 | filing |
| 23 Oct 2020filed 23 Oct 2020 | Immunomedicsoption or derivative | SEC FORM 4 Code D | —390,460 | filing |
| 4 Mar 2020filed 5 Mar 2020 | Immunomedicsoption or derivative | SEC FORM 4 Code A | —51,600 at $0.00 | filing |
| 6 Sep 2019filed 10 Sep 2019 | Immunomedicsoption or derivative | SEC FORM 4 Code A | —67,480 at $0.00 | filing |
| 14 Mar 2019filed 18 Mar 2019 | Immunomedicsoption or derivative | SEC FORM 4 Code A | —51,320 at $0.00 | filing |
| 14 Mar 2019filed 18 Mar 2019 | Immunomedicsoption or derivative | SEC FORM 4 Code A | —25,660 at $0.00 | filing |
| 14 Sep 2018filed 18 Sep 2018 | Immunomedicsoption or derivative | SEC FORM 4 Code A | —44,400 at $0.00 | filing |
| 10 Nov 2017filed 14 Nov 2017 | Immunomedicsoption or derivative | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.